Home Medical Devices Global Ultrasound Gels Market Size, Manufacturers, Report to 2031

Ultrasound Gels Market

Ultrasound Gels Market Size, Share & Trends Analysis Report By Type (Sterile, Non- Sterile), By End-User (Hospitals, Diagnostic Centre, Clinics, Ambulatory Centre) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRMD55339DR
Study Period 2019-2031 CAGR 3%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 98.04 Million
Forecast Year 2031 Forecast Year Market Size USD 127.92 Million
Largest Market North America Fastest Growing Market Europe
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global ultrasound gels market size was valued at USD 98.04 million in 2022. It is estimated to reach USD 127.92 million by 2031, growing at a CAGR of 3% during the forecast period (2023–2031). The use of ultrasound gels will increase because of the rigorous regulations that hospitals must follow regarding the handling and cleaning medical equipment to prevent any potentially contagious epidemic.

In all ultrasound operations, ultrasound gel is utilized as a coupling medium to replace air between the transducer and the patient's skin since air makes it difficult for ultrasonic waves to pass through. An aqueous medium must be positioned between the ultrasonic probe and the skin for a clean image. A coupling agent used in these treatments is ultrasound gel, an aqueous medium. Carbopol, propylene glycol, phenoxyethanol, glycerin, colors, scent, and water comprise its constituent parts. Depending on the producer, they are made with various ratios and compositions, and the recipes are secret.

Market Dynamics

Global Ultrasound Gels Market Drivers

Increase in Ultrasound Procedural Volume

Gels for ultrasonography are necessary while using ultrasound. Therefore, their rising use during scans is projected to increase demand for them in the market. Due to its accessibility, mobility, and affordability, ultrasound is quickly rising to the top of the list of the most widely used and effective cross-sectional imaging modalities. Both diagnostic and therapeutic methods involve ultrasound gels. The use of the imaging modality in point-of-care diagnosis and bedside monitoring has expanded due to its capacity to deliver rapid, safe, and minimally intrusive important clinical information. Due to the global lack of radiologists, non-radiologists, such as qualified nurses or paramedics, also handle ultrasound equipment. As a result of the tremendous benefits ultrasound gels have over other imaging modalities, the frequency of ultrasound scans is predicted to increase exponentially throughout the projection period.

Additionally, ultrasounds are the only reliable diagnostic method for identifying intrauterine growth retardation that has clinically decreased the incidence of neonatal morbidity and mortality worldwide. Additionally, as the need for regular fetal health monitoring throughout pregnancy has grown, so too have gynecologist visits, which further increases the need for ultrasound gels.

Availability of Easily Cleanable Ultrasound Gels

Cleaning and disinfecting ultrasonic probes are essential during transesophageal, surgical, endovaginal, and endorectal examinations. The risk of cross-contamination increases because substitutes for ultrasound gels, like guar gum and corn starch, are far stickier and more difficult to clean than commercially available ultrasound gels. For instance, if the employed coupling agent is extremely thick or sticky, it will be challenging for the sinologist to clean the probes, and any gel left behind might serve as an infection source.

Additionally, it is anticipated that the use of ultrasound gels will increase because of the rigorous regulations that hospitals must follow regarding the handling and cleaning of medical equipment to prevent any potentially contagious epidemic.

Global Ultrasound Gels Market Restraint

Availability of Alternatives

Guar gum, maize starch, glucomannan, xanthan, saline, and water are often used substitutes for commercially supplied ultrasonic gels. The quality of the image created for the sake of its interpretation is the most crucial factor when comparing various options. According to several studies, most of these substitutes deliver ultrasound scans with sufficient image quality.

Additionally, these alternatives have the potential to replace ultrasound gels due to their low cost and ease of procurement. The most closely correlated performance between these alternatives and commercial ultrasound gels, Aquasonic, was found to be xanthan gum, according to a 2018 American Institute of Ultrasound in Medicine analysis. This prevented the industry from expanding by making xanthan gum a viable substitute for ultrasonic gels already on the market.

Global Ultrasound Gels Market Opportunities

Increasing Demand for Devices

There is a large market opportunity for ultrasound gel due to the rising prevalence of handheld ultrasound devices and the growing number of ultrasound units in clinics. There is a rising need for ultrasound gel to guarantee the best image quality as more clinics and hospitals employ ultrasound technology in their medical procedures. Future market growth is anticipated to be fueled by this trend as demand for ultrasound operations continues to climb around the globe.

Regional Analysis

Based on region, the Global Ultrasound Gels Market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant Global Ultrasound Gels Market shareholder and is estimated to grow at a CAGR of 2.6% over the forecast period. This can be linked to elements including the expanding use of ultrasound technology in primary care settings, easier availability of ultrasound gels, and the existence of nations with large healthcare expenditures and effective reimbursement systems—several of the leading market participants, including Parker Laboratories and Eco-med. Headquarters for H.R. Pharmaceuticals and National Therapy Products are located in North American nations. Additionally, the region's growing need for pediatric imaging and the burden of chronic sickness is anticipated to fuel the ultrasound gels market throughout the projection period. Additionally, expanding awareness, escalating the need for various diagnostic techniques, and endorsements by several healthcare organizations are anticipated to drive market expansion in this area.

For instance, in March 2021, the American Institute of Ultrasound in Medicine (AIUM) reapproved the instructions for safely handling, using coupling gel, cleaning, and preparing external and internal ultrasound probes. These approvals are anticipated to increase the usefulness of ultrasound gels in the area. Therefore, North America is predicted to see expansion in the studied market over the study period due to the rise in chronic conditions that call for ultrasound and product releases.

Europe is anticipated to exhibit a CAGR of 6.07% over the forecast period. The demand for ultrasound gels in the market is anticipated to increase due to the expanding usage of ultrasound technology in cardiac and prenatal care. Additionally, the growing governmental and private investment in initiatives like creating cutting-edge ultrasound technology, educational initiatives, and teleradiology services will probably support market expansion. The number of ultrasound procedures is rising due to effective reimbursement systems and the growing burden of chronic disease. Additionally, a sizable amount of ultrasound gels are used during testing for abdominal, pelvic, renal, and bladder examinations that general practitioners suggest. Due to the increasing demand for these ultrasound imaging tests, Europe's consumption of ultrasound gels is projected to increase.

The Asia-Pacific market is expected to surge in demand during the forecast period. Its sizeable market share has been influenced by rising hospital admissions for acute stomach discomfort and the incidence of cardiovascular diseases. Due to restricted access to CT and MRI imaging modalities, more lung ultrasounds on COVID-19 patients are being conducted, particularly in India, Indonesia, and the Philippines. This has led to the recent expansion of the sterile ultrasound gels market. Most hospitals in Japan are outfitted with the most modern and cutting-edge ultrasound equipment. Over time, the use of ultrasound gels has remained largely constant.

However, the use of ultrasound equipment in primary care clinics and centers has increased recently. This is attributable to the introduction of portable probes at reasonable pricing and rising interest among doctors in early clinical treatments. As a result, demand for packet-sized and bottled ultrasound gels is anticipated, propelling market expansion.

In Latin America, the two ultrasound exams that are carried out most commonly in Latin America are breast and abdominal. An estimated 40% of all radiological imaging procedures in Latin America use abdominal ultrasound scanning. The second-most frequent ultrasound study is a breast ultrasound. More hospital admissions for lower abdominal discomfort each year lead to increased abdominal ultrasonography procedures. The need for ultrasound gels is expected to increase since breast and abdominal ultrasounds require a substantial amount of ultrasound gels. However, factors predicted to restrain the market include a lack of training and a paucity of trained radiologists for operating ultrasound offices in Latin America.

In the Middle East and Africa, compared to other GCC nations, this region has a much higher need for maternity and pediatric healthcare services. The primary application areas for ultrasound equipment are in pediatric and prenatal care. Over the projection period, it is predicted that the availability of required health insurance coverage for lifestyle illnesses and rising private sector involvement in healthcare would lead to a rise in the consumption of ultrasound gels.

Report Scope

Report Metric Details
By Type
  1. Sterile
  2. Non- Sterile
By End-User
  1. Hospitals
  2. Diagnostic Centre
  3. Clinics
  4. Ambulatory Centre
Company Profiles Compass Health Brands ECO-MED National Therapy Products H.R. Pharmaceuticals Inc. Sonogel Vertriebs Medline Industries Inc. Tele-Paper Malaysia Parker Laboratories Ultragel Kft
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global ultrasound gels market is bifurcated into type and end-user

Based on type, the global ultrasound gels market is bifurcated into sterile ultrasound gel, non-sterile ultrasound gel

The non-sterile segment dominates the global market and is projected to exhibit a CAGR of 2.74% over the forecast period. This is explained by the fact that ultrasonic treatments are frequently carried out on whole or unbroken skin, where sterility is not an issue. The cost-effectiveness of non-sterile gels over sterile ultrasonography drives up its utilization. In addition, the market is anticipated to be driven by the benefits of ultrasonic gels, such as their lack of odor, color, and formaldehyde.

Based on end-users, the global ultrasound gels market is bifurcated into hospitals, diagnostic centers, clinics, and ambulatory centers.

The hospital segment owns the global market and is predicted to exhibit a CAGR of 2.74% over the forecast period. Compared to other end users, the hospital facility performs a greater quantity and variety of ultrasound investigations. A hospital may need at least three ultrasound scanners for general radiology, obstetrics and gynecology, and heart scanning. As a result, ultrasonography has the biggest market share because of its greater utilization rate and wide patient base. On the other hand, during urgent care visits and bedside monitoring, ultrasonography is quickly rising to the top of the diagnostic toolkit.

As a result, an increase in hospital scans is anticipated throughout the projection period. This will directly impact the expansion of the ultrasonic gels market. The need for ultrasound gel is also anticipated to rise as private hospitals expand to handle the rising burden of chronic sickness.

Market Size By Type

Market Size By Type
  • Sterile
  • Non- Sterile
  • Recent Developments

    • May 2023- Ultrasound Gel Bottles Can Be Replaced with Single-Use Surgilube® Packets. Surgilube is a desirable substitute for multi-use ultrasound gel bottles due to its chemical composition and hygienic single-use packaging.
    • July 2022- New stamp-sized ultrasonic adhesives from MIT engineers create crystal-clear pictures of the heart, lungs, and other interior organs.

    Top Key Players

    Ultrasound Gels Market Share of Key Players

    Ultrasound Gels Market Share of Key Players
    Compass Health Brands ECO-MED National Therapy Products H.R. Pharmaceuticals Inc. Sonogel Vertriebs Medline Industries Inc. Tele-Paper Malaysia Parker Laboratories Ultragel Kft Others

    Frequently Asked Questions (FAQs)

    How big is the ultrasound gels market?
    The global ultrasound gels market size was valued at USD 98.04 million in 2022. It is estimated to reach USD 127.92 million by 2031, growing at a CAGR of 3% during the forecast period (2023–2031).
    Europe region has the highest growth rate in the ultrasound gels market.
    Increase in ultrasound procedural volume is some key driver supporting the growth of the ultrasound gels market.
    Key verticals adopting ultrasound gels include: - Compass Health Brands, ECO-MED, National Therapy Products, H.R. Pharmaceuticals Inc., Sonogel Vertriebs, Medline Industries Inc., Tele-Paper Malaysia, Parker Laboratories, Ultragel Kft.
    Non-sterile segment is the leading segment for the market during forecast period.

    We are featured on :